Search

Your search keyword '"Multiple sclerosis -- Prevention"' showing total 119 results
Start Over Descriptor "Multiple sclerosis -- Prevention"
119 results on '"Multiple sclerosis -- Prevention"'

1. Karolinska Institute Researchers Focus on Multiple Sclerosis (Effectiveness of Fewer Falls, an online group-based self-management fall prevention programme for people with multiple sclerosis: protocol of a randomised controlled trial)

Subjects
Multiple sclerosis -- Prevention, Clinical trials -- Analysis, Neurophysiology -- Analysis, Company business management, Health
Abstract

2025 JAN 24 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Investigators discuss new findings in multiple sclerosis. According to news reporting originating from [...]

Published
2025

2. Reports on Pain and Central Nervous System Findings from College of Applied Health Science Provide New Insights (Engaging Wheelchair and Scooter Users In the Co-design of an Mhealth Application for Fall Prevention and Management: Thematic ...)

Subjects
Falls (Accidents) -- Reports, Ambulation aids -- Reports, Multiple sclerosis -- Prevention, Central nervous system -- Reports, Health
Abstract

2024 DEC 6 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- New research on Pain and Central Nervous System is the subject of a [...]

Published
2024

3. Researchers Submit Patent Application, 'Diazepane Derivatives, Processes for their Preparation, and Uses thereof for the Amelioration, Prevention and/or Treatment of Mental and Neurological Diseases', for Approval (USPTO 20240246957)

Subjects
Movement disorders -- Prevention, Nervous system diseases -- Prevention, Multiple sclerosis -- Prevention, Health
Abstract

2024 AUG 16 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors [...]

Published
2024

4. New Multiple Sclerosis Study Findings Have Been Reported by a Researcher at Research Institute for Prevention of Non-Communicable Diseases (Perceived Social Isolation Among Patients With Multiple Sclerosis Suffering From Disease-Induced Pain ...)

Subjects
Communicable diseases -- Prevention, Multiple sclerosis -- Prevention
Abstract

2024 AUG 9 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Data detailed on multiple sclerosis have been presented. According to news originating from [...]

Published
2024

6. Patent Issued for Estrogen receptor beta ligands for the prevention and treatment of multiple sclerosis (MS) and other demyelinating, inflammatory and neurodegenerative diseases (USPTO 11673866)

Subjects
Multiple sclerosis -- Prevention, Phenols -- Intellectual property, Estrogen, Physical fitness, Health
Abstract

2023 JUL 8 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Board of Trustees of the University of Illinois (Urbana, Illinois, United States) [...]

Published
2023

8. Studies from Shanghai University of Traditional Chinese Medicine Further Understanding of Experimental Autoimmune Encephalomyelitis (Huangqi-guizhi-wuwu Decoction Regulates Differentiation of Cd4+t Cell and Prevents Against Experimental ...)

Subjects
Medical research, Medicine, Experimental, T cells, Multiple sclerosis -- Prevention, Medicine, Chinese, Encephalomyelitis -- Prevention, Health
Abstract

2024 MAR 29 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Research findings on Autoimmune Diseases and Conditions - Experimental Autoimmune Encephalomyelitis are discussed [...]

Published
2024

9. Data from University of Michigan Update Knowledge in Multiple Sclerosis (A nationwide update on prevalence of falls, injurious falls, concerns about falling, and fall prevention in persons with multiple sclerosis)

Subjects
Falls (Accidents) -- Surveys, Multiple sclerosis -- Prevention, Health, University of Michigan -- Surveys
Abstract

2024 MAR 29 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Current study results on multiple sclerosis have been published. According to news originating [...]

Published
2024

10. Researcher from Neuroscience Research Australia Provides Details of New Studies and Findings in the Area of Multiple Sclerosis (A custom-built step exergame training programme to prevent falls in people with multiple sclerosis: A multicentre ...)

Subjects
Falls (Accidents) -- Reports, Multiple sclerosis -- Prevention, Neurosciences -- Reports, Health
Abstract

2024 MAR 8 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Investigators publish new report on multiple sclerosis. According to news originating from Sydney, [...]

Published
2024

14. Researchers Submit Patent Application, 'A Substituted Amino-Pyrimidine Compound For Use In A Method For Treatment And Prevention Of Multiple Sclerosis', for Approval (USPTO 20210260060)

Subjects
Fingolimod -- Reports -- Methods -- Intellectual property, Multiple sclerosis -- Prevention, Pyrimidines -- Reports -- Methods -- Intellectual property, Physical fitness -- Reports -- Methods, Health
Abstract

2021 SEP 18 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- From Washington, D.C., NewsRx journalists report that a patent application by the [...]

Published
2021

15. Researchers Submit Patent Application, 'Estrogen Receptor Beta Ligands For The Prevention And Treatment Of Multiple Sclerosis (Ms) And Other Demyelinating, Inflammatory And Neurodegenerative Diseases', for Approval (USPTO 20210230121)

Subjects
Biochemistry, Fingolimod -- Intellectual property, Multiple sclerosis -- Prevention, Phenols -- Intellectual property, Estrogen, Physical fitness, Health
Abstract

2021 AUG 21 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- From Washington, D.C., NewsRx journalists report that a patent application by the [...]

Published
2021

16. EBViously Announces First Details of Its EBV-001 Vaccine Candidate for the Prevention of Epstein-Barr Virus (EBV)-Induced Diseases

Subjects
Multiple sclerosis -- Prevention, Vaccines -- Health aspects, Epstein-Barr virus -- Health aspects, Banking, finance and accounting industries, Business
Abstract

Presentation at the World Vaccine Congress 2023 EBV-infections associated with many cancers and multiple sclerosis Munich, Germany, April 3, 2023 - EBViously, a start-up developing novel vaccines based on next-generation [...]

Published
2023

17. Leading MS|PML Experts Recommend Genetic Testing to Prevent Fatal Brain Infection

Subjects
Infection control -- Health aspects, Multiple sclerosis -- Prevention, Infection -- Prevention, Genetic screening -- Health aspects, General interest, News, opinion and commentary, Tysabri (Medication) -- Health aspects
Abstract

NEWPORT BEACH: Emerald Lake Safety LLC and Population Bio, Inc. has issued the following news release: In an editorial in the journal Frontiers in Neurology, two leading multiple sclerosis (MS) [...]

Published
2023

18. Epstein-Barr Virus May Be Leading Cause

Subjects
Multiple sclerosis -- Prevention, Infection -- Prevention, Epidemiology -- Health aspects, Epstein-Barr virus -- Health aspects, General interest, News, opinion and commentary
Abstract

Multiple sclerosis, a progressive disease that affects 2,800,000 people worldwide and for which there is no definitive cure, likely is caused by infection with the Epstein-Barr virus, maintains a study [...]

Published
2022

19. Researchers from University of Texas MD Anderson Cancer Center Report Recent Findings in Peroxisome Proliferator-Activated Receptors (Mature Myelin Maintenance Requires Qki To Coactivate Ppar Beta-rxr Alpha-mediated Lipid Metabolism)

Subjects
Physical fitness -- Physiological aspects -- Reports, Lipids -- Physiological aspects -- Reports, Cancer -- Prevention, Cancer prevention -- Physiological aspects -- Reports, Cancer research -- Reports -- Physiological aspects, Multiple sclerosis -- Prevention, Proteins -- Physiological aspects -- Reports, Health, University of Texas. M.D. Anderson Cancer Center -- Reports
Abstract

2020 OCT 24 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on Proteins - Peroxisome Proliferator-Activated Receptors. According to [...]

Published
2020

20. Medical College of Wisconsin Researchers Update Knowledge of Experimental Autoimmune Encephalomyelitis (Targeting transmembrane-domain-less MOG expression to platelets prevents disease development in experimental autoimmune encephalomyelitis)

Subjects
Genetic research, Multiple sclerosis -- Prevention, Genetic engineering, Hematopoietic stem cells, Myelin proteins, Encephalomyelitis -- Prevention, Health
Abstract

2022 NOV 18 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- New study results on experimental autoimmune encephalomyelitis have been published. According to news [...]

Published
2022

22. Study Results from Karolinska Institute Update Understanding of Multiple Sclerosis (Online self-management fall prevention intervention for people with multiple sclerosis: a feasibility study protocol of a parallel group randomised trial)

Subjects
Falls (Accidents), Multiple sclerosis -- Prevention, Neurophysiology, Company business management, Health
Abstract

2022 JUL 29 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- New study results on multiple sclerosis have been published. According to news originating [...]

Published
2022

23. UV radiation suppresses experimental autoimmune encephalomyelitis independent of vitamin D production

Author

Becklund, Bryan R., Severson, Kyle S., Vang, Souriya V., and DeLuca, Hector F.

Subjects
Encephalomyelitis -- Risk factors, Encephalomyelitis -- Development and progression, Encephalomyelitis -- Prevention, Multiple sclerosis -- Risk factors, Multiple sclerosis -- Development and progression, Multiple sclerosis -- Prevention, Ultraviolet radiation -- Health aspects, Alfacalcidol -- Health aspects, Calcifediol -- Health aspects, Vitamin D -- Health aspects, Science and technology
Abstract

Although the exact cause of multiple sclerosis (MS) is unknown, a number of genetic and environmental factors are thought to influence MS susceptibility. One potential environmental factor is sunlight and the subsequent production of vitamin D. A number of studies have correlated decreased exposure to UV radiation (UVR) and low serum 25-hydroxyvitamin [D.sub.3] [25(OH)[D.sub.3]] levels with an increased risk for developing MS. Furthermore, both UVR and the active form of vitamin D, 1[alpha],25-dihydroxyvitamin [D.sub.3], suppress disease in the experimental autoimmune encephalomyelitis (EAE) animal model of MS. These observations led to the hypothesis that UVR likely suppresses disease through the increased production of vitamin D. However, UVR can suppress the immune system independent of vitamin D. Therefore, it is unclear whether UVR, vitamin D, or both are necessary for the putative decrease in MS susceptibility. We have probed the ability of UVR to suppress disease in the EAE model of MS and assessed the effect of UVR on serum 25(OH)[D.sub.3] and calcium levels. Our results indicate that continuous treatment with UVR dramatically suppresses clinical signs of EAE. Interestingly, disease suppression occurs with only a modest, transient increase in serum 25 (OH)D3 levels. Further analysis demonstrated that the levels of 25(OH) D3 obtained upon UVR treatment were insufficient to suppress EAE independent of UVR treatment. These results suggest that UVR is likely suppressing disease independent of vitamin D production, and that vitamin D supplementation alone may not replace the ability of sunlight to reduce MS susceptibility. calcium | immune | multiple sclerosis | sunlight doi/10.1073/pnas.1001119107

Published
2010

24. Cannabis potential effects to prevent or attenuate SARS-COV2 contagion

Subjects
Medical marijuana -- Health aspects, Medical research -- Health aspects, Medicine, Experimental -- Health aspects, Multiple sclerosis -- Prevention, Business, Health, Health care industry
Abstract

2022 APR 24 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Letter on the CDC & FDA -- According to news reporting based on a preprint abstract, our [...]

Published
2022

25. Reports from University of Edinburgh Add New Data to Research in Epstein-Barr Virus (Prevention of MS Requires Intervention on the Causes of the Disease: Reconciling Genes, Epigenetics, and Epstein Barr Virus)

Subjects
Genes, Multiple sclerosis -- Prevention, Epigenetic inheritance, Epstein-Barr virus, Health, University of Edinburgh
Abstract

2022 MAR 11 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Data detailed on Epstein-Barr virus have been presented. According to news reporting from [...]

Published
2022

26. Epidemiology of multiple sclerosis in the Canary Islands (Spain); A study on the island of La Palma

Author

Hernandez, Miguel Angel

Subjects
Canary Islands -- Health aspects, Multiple sclerosis -- Research, Multiple sclerosis -- Prevention, Epidemiology, Health
Abstract

Byline: Miguel Angel Hernandez (1) Keywords: Key words Multiple sclerosis; prevalence; epidemiology; incidence Abstract: Objective: To determine the prevalence of multiple sclerosis (MS) on the Island of La Palma, Canary Islands, Spain. Methods: A population-based transverse study was carried out on the Island of La Palma (population: 81,507), from 1995 to 1998. The 15 December 1998 was established as prevalence day. Sources of information were periodically obtained from case records from public primary care centres, private hospitals, private centres, magnetic resonance units and others. In accordance with the Poser criteria all cases of definite or probable MS were included. Results: 34 cases of MS were found on prevalence day (9 male and 25 female): 32 cases were clinically definite and 2 were clinically probable MS. Crude prevalence was 42/100,000. Incidence during time of study was 2.25/100,000. Conclusions: The island of La Palma could be considered as an area of medium-high risk, the risk being higher than that expected because of the geographical latitude of the island. This study confirms the hypothesis of the high prevalence of MS in Spain. We have not found significant clinical differences in MS patients from those in other studies. Author Affiliation: (1) Service of Neurology, Hospital Ntra. Sra. de Candelaria, C/Rosario s/n, 38010 Santa Cruz de Tenerife, Canary Islands, Spain. mhernandezp@meditex.es, ES Article note: Received: 7 August 2000, Received in revised form: 22 November 2001, Accepted: 16 April 2002 Correspondence to M. A. Hernandez

Published
2002

27. Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand

Author

Bielekova, Bibiana, Goodwin, Bonnie, Richert, Nancy, Cortese, Irene, Kondo, Takayuki, Afshar, Ghazaleh, Gran, Bruno, Eaton, Joan, Antel, Jack, Frank, Joseph A., McFarland, Henry F., and Martin, Roland

Subjects
Interferon -- Product development, Interferon -- Dosage and administration, Magnetic resonance imaging -- Usage, Multiple sclerosis -- Diagnosis, Multiple sclerosis -- Drug therapy, Multiple sclerosis -- Prevention, Multiple sclerosis -- Research, Myelin proteins -- Health aspects, Myelin proteins -- Research
Abstract

Myelin-specific T lymphocytes are considered essential in the pathogenesis of multiple sclerosis. The myelin basic protein peptide (a.a. 83-99) represents one candidate antigen; therefore, it was chosen to design an altered peptide ligand, CGP77116, for specific immunotherapy of multiple sclerosis. A magnetic resonance imaging-controlled phase II clinical trial with this altered peptide ligand documented that it was poorly tolerated at the dose tested, and the trial had therefore to be halted. Improvement or worsening of clinical or magnetic resonance imaging parameters could not be demonstrated in this small group of individuals because of the short treatment duration. Three patients developed exacerbations of multiple sclerosis, and in two this could be linked to altered peptide ligand treatment by immunological studies demonstrating the encephalitogenic potential of the myelin basic protein peptide (a.a. 83-99) in a subgroup of patients. These data raise important considerations for the use of specific immunotherapies in general., Author(s): Bibiana Bielekova [1]; Bonnie Goodwin [1]; Nancy Richert [2]; Irene Cortese [1]; Takayuki Kondo [1]; Ghazaleh Afshar [1]; Bruno Gran [1]; Joan Eaton [1]; Jack Antel [3]; Joseph A. [...]

Published
2000

28. Vitamin D and multiple sclerosis

Author

Stevens, Erika

Subjects
Multiple sclerosis -- Prevention, Multiple sclerosis -- Care and treatment, Alfacalcidol -- Health aspects, Calcifediol -- Health aspects, Vitamin D -- Health aspects, Dietary supplements -- Usage, Dietary supplements -- Health aspects, Business, Food/cooking/nutrition, Health, Health care industry
Published
2010

30. New therapy decreases cells associated with multiple sclerosis, prevents disease in mice

Author

Ayshford, Emily

Subjects
Blood proteins, Multiple sclerosis -- Prevention, News, opinion and commentary, Sports and fitness, University of Chicago
Abstract

Byline: Emily Ayshford Multiple sclerosis, an autoimmune disease of the central nervous system that affects millions worldwide, can cause debilitating symptoms for those who suffer from it. Though treatments exist, [...]

Published
2020

31. Birmingham scientists 're-train' immune system to prevent attack of healthy cells in new UK study into autoimmune diseases

Subjects
Medical research, Immune system, Multiple sclerosis -- Prevention, Scientists, Proteins, Business, international, University of Birmingham
Abstract

London: University of Birmingham, UK Government has issued the following news release: The body's immune system can be re-wired to prevent it from recognising its own proteins which, when attacked [...]

Published
2020

32. Trigger for autoimmune disease identified

Subjects
Lupus -- Prevention, Physical fitness, B cells, Medical research, Multiple sclerosis -- Prevention, Health
Abstract

2017 MAY 27 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Researchers at National Jewish Health have identified a trigger for autoimmune diseases [...]

Published
2017

33. After 'nightmare' of pain, woman with MS questions why drug shortages aren't prevented

Subjects
Shortages, Generic drugs, Multiple sclerosis -- Prevention, Pain management, Product shortage, General interest, News, opinion and commentary
Abstract

Byline: CBC News It's like you're 'burning from the inside out.' That's how Melanie Gaunt, a 46-year-old Nova Scotian with multiple sclerosis, describes the pain when she can't get the [...]

Published
2018

37. The ongoing battle against multiple sclerosis

Subjects
Multiple sclerosis -- Prevention, Diet -- Health aspects, General interest, News, opinion and commentary
Abstract

DANA JACOBSON: They imprint on all the things that we do. Our next topic, the ongoing battle against multiple sclerosis. It`s debilitating-- debilitating disease that impacts an estimated four hundred [...]

Published
2017

38. Healthy lifestyle effectively prevents Alzheimer's, MS, Iranian neurologist says

Subjects
Multiple sclerosis -- Prevention, Brain damage -- Prevention, Alzheimer's disease -- Prevention, News, opinion and commentary
Abstract

IRAN DAILY A Healthy lifestyle plays a key role in prevention of Alzheimer's and multiple sclerosis (MS), Iranian neurologist Dr. Nahid Beladi-Moqaddam told Iran Daily.However, the main causes of these [...]

Published
2018

39. Prevention of EAE by PEGylated Antigenic Peptide

Subjects
Antigens, Vaccines, Peptides, Multiple sclerosis -- Prevention, T cells, Health
Abstract

2020 SEP 23 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Weekly -- According to news reporting based on a preprint abstract, our journalists obtained the following quote [...]

Published
2020

40. Corticosteroids and optic neuritis

Author

Silberberg, Donald H.

Subjects
Optic neuritis -- Drug therapy, Multiple sclerosis -- Prevention, Corticosteroids -- Health aspects
Abstract

Further studies specifically investigating the effect of corticosteroids for optic neuritis on the onset of multiple sclerosis need to be conducted. Optic neuritis is a chronic inflammation of the optic nerves and is often a clinical sign of multiple sclerosis. Corticosteroids are anti-inflammatory drugs. Past trials of corticosteroids indicate that they do not improve recovery from optic neuritis or prevent the development of clinical multiple sclerosis. A study reporting beneficial effects of high dose, intravenous corticosteroids on the development of multiple sclerosis may be flawed in design and focus. Study patients were aware of the treatment they received. Their physical responses to treatment may have been biased by the psychological effects of such knowledge. In addition, the data were taken from a separate study that was not designed to determine the effects of corticosteroids on multiple sclerosis.

Published
1993

41. Sunnier Days in Youth May Mean Less Odds of MS Later

Subjects
Ultraviolet radiation -- Health aspects, Sun exposure -- Health aspects, Multiple sclerosis -- Prevention, Vitamin D -- Health aspects, Health
Abstract

WEDNESDAY, March 7, 2018 (HealthDay News) -- Living in sunnier climes when young might help shield you from multiple sclerosis decades later, new research suggests. The main factor may be [...]

Published
2018

42. MS Drug Shows Promise in Preventing Heart Conditions

Author

Tate, Nick

Subjects
Multiple sclerosis -- Prevention, News, opinion and commentary
Abstract

Byline: Nick Tate A drug used to treat multiple sclerosis may also hold promise for treating the heart condition known as cardiac hypertrophy - thickening of the cardiac muscle - [...]

Published
2013

44. Children born to mothers who drink four glasses of milk daily and have a high dietary intake of vitamin D during pregnancy have a much lower risk of developing multiple sclerosis later in life

Subjects
Milk -- Health aspects -- Research, Multiple sclerosis -- Prevention, Alfacalcidol -- Health aspects, Calcifediol -- Health aspects, Vitamin D -- Health aspects, Business, Food and beverage industries
Abstract

Children born to mothers who drink four glasses of milk daily and have a high dietary intake of vitamin D during pregnancy have a much lower risk of developing multiple [...]

Published
2010

45. Reports from Max-Planck-Institute for Biochemistry Highlight Recent Findings in Autoimmune Diseases and Conditions (Dietary non-fermentable fiber prevents autoimmune neurological disease by changing gut metabolic and immune status)

Subjects
Biochemistry, Medical research, Immunotherapy, Nervous system diseases -- Prevention, Multiple sclerosis -- Prevention, Health
Abstract

2018 AUG 29 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- Data detailed on Immune System Diseases and Conditions - Autoimmune Diseases and Conditions have been [...]

Published
2018

46. CLINICAL MATTERS: Smoking and MS

Subjects
Multiple sclerosis -- Prevention, Smoking -- Influence, Smoking -- Health aspects, Chemicals, plastics and rubber industries, Pharmaceuticals and cosmetics industries
Abstract

Contrary to earlier reports, smoking does not provide any protection against multiple sclerosis, according to a study published in the October 9 issue of the journal Neurology. Copyright: CMP Information [...]

Published
2007

47. Granalix BioTechnologies Introduces Novel Food Additive Based on Pomegranate Oil for Protection From Neurodegenerative Diseases

Subjects
Bovine spongiform encephalopathy -- Prevention, Biotechnology, Food additives, Nervous system diseases -- Prevention, Monoglycerides, Multiple sclerosis -- Prevention, Business, News, opinion and commentary
Abstract

JERUSALEM, September 28, 2016 /PRNewswire/ -- https://granalix.com/ today announced the commercial launch of GranaGard(TM) a food supplement based on pomegranate oil that was shown to prevent neurodegeneration diseases in mouse [...]

Published
2016

48. DRUG MAY PREVENT, REDUCE PROGRESSION OF MS IN MICE

Subjects
B cells, Multiple sclerosis -- Prevention, News, opinion and commentary, American Academy of Neurology
Abstract

MINNEAPOLIS -- The following information was released by the American Academy of Neurology (AAN): The experimental drug laquinimod may prevent the development or reduce the progression of multiple sclerosis (MS) [...]

Published
2016

49. National Multiple Sclerosis Society, Michigan Chapter to Host a Detroit Area Fall Prevention Course for Healthcare Professionals & Caregivers

Subjects
Caregivers, Medical personnel, Associations, Multiple sclerosis -- Prevention, Business, National Multiple Sclerosis Society
Abstract

Franklin, MI, August 18, 2016 --(PR.com)-- Attention Healthcare Professionals and Caregivers - Sharon Claye, President and Owner of Fall Prevention Training Services, LLC., in collaboration with the National Multiple Sclerosis [...]

Published
2016

50. The Road to a Cure

Author

DAVID, ANNA

Subjects
Multiple sclerosis -- Prevention, Benefit performances -- Planning, Arts, visual and performing, General interest
Published
2001

Catalog

Books, media, physical & digital resources
See catalog results